Determination of Oxaceprol in Rat Plasma by Lc-Ms/Ms and Its Application in A Pharmacokinetic Study

Jifeng Gu,Nianzu Chen,Guoqiang Ding,Zhen Zhang
DOI: https://doi.org/10.1016/j.jpba.2010.08.011
IF: 3.571
2010-01-01
Journal of Pharmaceutical and Biomedical Analysis
Abstract:A sensitive method for the quantification of oxaceprol in rat plasma using high-performance liquid chromatography–tandem mass spectrometry (LC–MS/MS) was developed. Sample pretreatment involved a simple protein precipitation by the addition of 60μL of acetonitrile–methanol (1:2, v/v) to 20μL plasma sample volume. Separation was achieved on a Dikma ODS-C18 (5μm, 150mm×4.6mm) reversed-phase column at 40°C with acetonitrile/0.1% formic acid–4mM ammonium acetate in water (35:65,v/v) at a flow rate of 0.6mL/min. Detection was performed using an electrospray ionization (ESI) operating in negative ion multiple reaction monitoring (MRM) mode by monitoring the ion transitions from m/z 172→130 (oxaceprol) and m/z 153→109 (protocatechuic acid, internal standard). The calibration curve of oxaceprol in plasma showed good linearity over the concentration range of 1.25–800ng/mL. The limit of detection and limit of quantification were 0.400ng/mL and 1.25ng/mL, respectively. Intra- and inter-day precisions in all samples were within 15%. There was no matrix effect. The validated method was successfully applied to a preclinical pharmacokinetic study of oxaceprol in rats. After oral administration of 20mg/kg oxaceprol to rats, the main pharmacokinetic parameters Tmax, Cmax, T1/2, Vz/F and AUC0–t were 1.4h, 1.2μg/mL, 2.3h, 19.7L/kg and 3.4mgh/L, respectively.
What problem does this paper attempt to address?